Question 1

Who owns NSRX?

Accepted Answer

NASUS PHARMA LTD (NSRX) is held by 5 institutional investors that disclose positions via SEC 13F filings. The largest disclosed holder is BALYASNY ASSET MANAGEMENT L.P. as of Q1 2026.

Question 2

Are institutions buying or selling NSRX?

Accepted Answer

In Q1 2026, 4 institutions opened or increased positions in NASUS PHARMA LTD while 0 reduced or exited — a net buying quarter.

Question 3

What is the Smart Money Verdict on NSRX?

Accepted Answer

The Smart Money Verdict combines four independent sources (institutional 13F activity, insider trades, activist filings, and congressional trades) into a single assessment for NASUS PHARMA LTD.

Question 4

How many hedge funds hold NSRX?

Accepted Answer

5 institutional investors report holding NASUS PHARMA LTD (NSRX) as of Q1 2026, based on SEC 13F filings.

Question 5

Is institutional money flowing into NSRX?

Accepted Answer

As of Q1 2026, tracked institutions in NASUS PHARMA LTD show 4 buyers versus 0 sellers — net inflows.

Fund	Action	Shares	Value	Weight	Est. P&L	Conviction
BALYASNY ASSET MANAGEMENT L.P.	New	898,473	$2M	0.0%	-38.32%	36
Hudson Bay Capital Management LP	New	134,771	$299,192	0.0%	-38.32%	32
UBS Group AG	Increased	3,094(+718.5%)	$6,869	0.0%	-42.46%	18
MORGAN STANLEY	Unchanged	2,000	$4,440	0.0%	-61.19%	0
HRT FINANCIAL LP	New	38,897	$86	0.0%	-38.32%	15

NASUS PHARMA LTD

Continue exploring

Other Healthcare stocks held by institutions